Adcytherix
Develops antibody-drug conjugate cancer therapies for patients with cancers resistant to current treatments
Highlights
- Young companyFounded 2024
- New on EvolcAdded 2026-11-09
About Adcytherix
Adcytherix is a clinical-stage biopharmaceutical company developing next-generation antibody-drug conjugates (ADCs) for oncology. Its approach combines clinically validated targets with payloads derived from approved cancer drugs and optimized conjugation designs.
The company focuses on cancers with unmet medical needs, including cancers resistant to current-generation ADCs. It was founded in 2024 and is headquartered in Marseille, France.
Product: Next-generation antibody-drug conjugate therapies for oncology.
Jobs at Adcytherix
More biotech & pharma companies
Ademtech
Magnetic particles and molecular diagnostic kits for IVD, life sciences and forensic laboratoriesNew on EvolcAdhexpharma
Develops and manufactures pharmaceutical patches and oral films for pharmaceutical and biotechnology companiesNew on EvolcAdocia
Develops clinical-stage treatments for diabetes and obesity for patients with metabolic diseasesNew on EvolcAdragos Pharma
Contract development and manufacturing for pharma and biotech clients in Europe, Japan and North AmericaAdvesya
Clinical-stage biotech developing IL-1RAP-targeted CAR T-cell and ADC treatments for cancer and autoimmune diseasesNew on EvolcAelis Farma
Develops CB1-targeted drug candidates for people with cannabis-related disorders and cognitive deficitsNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Content management
- WixHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- ReactMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
- Page markupsoftware structure signature
Monitoring
- SentryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.